Target type: biologicalprocess
The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered. [GOC:mtg_signal, GOC:mtg_signaling_feb11, GOC:signaling]
Signaling is a fundamental biological process that allows cells to communicate with each other and their environment. It involves the transmission of information from one cell to another, or from one part of a cell to another. This communication is essential for coordinating cellular activities, such as growth, development, metabolism, and response to stimuli. Signaling pathways are intricate networks of interacting molecules that relay signals from the outside world to the inside of cells. These pathways involve a series of events that begin with the binding of a signaling molecule, known as a ligand, to a specific receptor protein on the cell surface or inside the cell. This binding initiates a cascade of events that ultimately results in a cellular response. There are different types of signaling pathways, each with its own specific mechanism and function. Some common types include:
1. **Autocrine signaling:** A cell signals itself.
2. **Paracrine signaling:** A cell signals a nearby cell.
3. **Juxtacrine signaling:** A cell signals a directly adjacent cell.
4. **Endocrine signaling:** A cell signals a distant cell through the bloodstream.
5. **Synaptic signaling:** A specialized type of paracrine signaling that occurs between neurons.
Each signaling pathway involves a series of steps that can be summarized as follows:
**1. Reception:** The signaling molecule binds to a specific receptor protein on the cell surface or inside the cell.
**2. Transduction:** The binding of the ligand to the receptor initiates a cascade of events that transduce the signal from the outside of the cell to the inside. This typically involves a series of protein interactions and modifications.
**3. Signal amplification:** The signal is amplified as it is passed down the signaling pathway, allowing a small number of signaling molecules to trigger a large cellular response.
**4. Response:** The signal ultimately reaches its target, which may be a gene, an enzyme, or another protein. This results in a specific cellular response, such as changes in gene expression, protein activity, or cellular behavior.
**Signaling pathways are highly regulated and can be influenced by a variety of factors, including:**
* **The concentration of signaling molecules**
* **The availability of receptors**
* **The activity of signaling proteins**
* **The presence of other signaling pathways**
**Dysregulation of signaling pathways can lead to a variety of diseases, including cancer, diabetes, and neurodegenerative disorders. Therefore, understanding signaling pathways is crucial for developing new therapies for these diseases.**'
"
Protein | Definition | Taxonomy |
---|---|---|
C-C chemokine receptor type 5 | A C-C chemokine receptor type 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P51681] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1,10-phenanthroline | 1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases | phenanthroline | EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor |
2,2'-dipyridyl | 2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'. 2,2'-Dipyridyl: A reagent used for the determination of iron. | bipyridine | chelator; ferroptosis inhibitor |
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
terfenadine | Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME. | diarylmethane | |
4,4'-dimethyl-2,2'-bipyridine | 4,4'-dimethyl-2,2'-bipyridine: structure in first source | ||
5,5'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-bipyridyl: structure in first source | bipyridines | |
neocuproine | neocuproine : A member of the class of phenanthrolines that is 1,10-phenanthroline bearing two methyl substituents at positions 2 and 9. neocuproine: Spectrophotometric determination of copper and ultramicro blood sugar determinations; structure; RN given refers to parent cpd | phenanthrolines | chelator; copper chelator |
2,2',2''-terpyridine | 2,2',2''-terpyridine: RN given refers to parent cpd 2,2':6',2''-terpyridine : A tridentate heterocyclic ligand that binds metals at three meridional sites giving two adjacent 5-membered MN2C2 chelate rings. | terpyridines | chelator |
5-methyl-1,10-phenanthroline | |||
3,4,7,8-tetramethyl-1,10-phenanthroline | |||
tak 779 | |||
aplaviroc | aplaviroc: a spiro-diketo-piperazine; a potent noncompetitive allosteric antagonist of the CCR5 receptor with concomitantly potent antiviral effects for HIV-1; structure in first source | ||
maraviroc | tropane alkaloid | ||
vicriviroc | vicriviroc: structure in first source | (trifluoromethyl)benzenes | |
tak-220 | TAK-220: structure in first source | ||
cp 481715 | quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyloctyl)amide: a CCR1 antagonist and NSAID; structure in first source | ||
ancriviroc | Ancriviroc: CCR5 receptor antagonist | aromatic carboxylic acid; pyridinemonocarboxylic acid | |
variecolin | variecolin: structure in first source | enal; sesterterpenoid | Aspergillus metabolite |
ucb 35625 | UCB 35625: J-113863 is the (trans)-isomer; structure in first source | ||
amd 070 | mavorixafor: a derivative of AMD3100; a CXCR4 blocker | aminoquinoline | |
cenicriviroc | cenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). cenicriviroc: an inhibitor of HIV-1 | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist |
19,20-epoxycytochalasin q | 19,20-epoxycytochalasin Q: from Xylaria sp.; structure in first source | ||
fuscin | fuscin: antibacterial pigment produced by the fungus Didiodendron fuscom; minor descriptor (75-82); online & Index Medicus search BENZOPYRANS (75-82) |